Target Audience:
The target audience for this meeting includes: 1) Basic researchers who study mechanisms of autoimmune diseases, 2) Clinical researchers who explore new treatments in the treatment of autoimmune diseases, including biologics, drugs and gene therapy, 3) Physicians who take care of patients with autoimmune diseases, including systemic lupus erythematosus, rheumatoid arthritis, Sjogren’s syndrome, diabetes, multiple sclerosis, autoimmune endocrine diseases, 4) Young physicians and researchers in training
Meeting objective:
At the completion of the meeting the participants should: 1) be able to discuss mechanisms that regulate tolerance and autoimmunity, 2) understand how organ specific and systemic autoimmune diseases arise, 3) understand the rational for the use of biologics (for example anti-TNF, IL-1 inhibitors), drugs (for example cyclosporin, FK506) and gene therapy in the treatment of autoimmune diseases, 4) plan research that will improve the welfare of patients with autoimmune diseases, 5) deliver better care to patients with organ specific and systemic autoimmune diseases.